Vaccine

London's Telegraph reports that results from a Phase 1 clinical trial evaluating Oxford University's COVID-19 vaccine candidate ChAdOx1 nCoV-19 [ADZ1222 by licensee AstraZeneca (NYSE:AZN)] in healthy volunteers showed that it triggered a "double defense" immune response against the SARS-CoV-2 virus. Researchers noted that administration of the candidate produced both antibodies and killer T cells. The…

ISSAM AHMED, AFP 15 JULY 2020 The US biotech firm Moderna said Tuesday it would enter the final stage of human trials for its COVID-19 vaccine on July 27, after promising early results were published in an influential journal. The Phase 3 trial will recruit 30,000 participants in the US, with half to receive the…

The first coronavirus vaccine to be tested in the U.S. boosted the immune systems of the study's participants and is being hailed a major step in the right direction towards eradicating COVID-19.“No matter how you slice this, this is good news,” Dr. Anthony Fauci told The Associated Press.The vaccine, which was developed by researchers at the National…

A team that includes researchers from Emory University released findings Tuesday of closely-watched work to create a COVID-19 vaccine that showed some positive results, but more work is needed to be sure it is safe. The findings showed high levels of neutralizing antibody activity that were above the average levels seen in blood serum obtained…

(Reuters) - Drugmakers partnered with the U.S. government are on track to begin actively manufacturing a vaccine for COVID-19 by the end of the summer, a senior administration official said on Monday. FILE PHOTO: A small bottle labeled with a "Vaccine" sticker is held near a medical syringe in front of displayed "Coronavirus COVID-19" words…